ÂÜÀòÂÒÂ×

Serguei Nabirotchkine, PhD has a diverse and extensive work experience in the field of biology and genetics. Serguei co-founded and served as the Chief Biology Officer at Pharnext since 2007. In this role, they developed and applied a systems biology approach to study rare and common human diseases, focusing on discovering disease signaling pathways and identifying potential therapeutics. Serguei led research projects on various diseases including CNS diseases, PNS diseases, metabolic diseases, immune diseases, cardiovascular diseases, cancer, muscular dystrophy, polycystic kidney disease, and SARS-CoV-2. Two combination therapies discovered under their leadership showed promising results in clinical trials for Charcot-Marie-Tooth disease and Alzheimer's disease.

Prior to Pharnext, Serguei worked at Serono Genetics Institute as the Director of the "Model organisms" Department from 2001 to 2006. Serguei was responsible for the development and genetic/functional analysis of non-mammalian genetic models of human neurodegenerative, mental, and inflammatory diseases. Serguei also served as a member of the Institutional Genetics Evaluation Committee.

Before that, they held a post-doctoral position at Institut Gustave Roussy from 1993 to 2001, where they worked in the UMR 8122 research unit. Serguei also had a post-doctoral position at the German Cancer Research Centre (DKFZ) from 1992 to 1993, where they worked in the Department of Developmental Genetics. Furthermore, from 1985 to 1992, they worked as a Senior Scientist and Group Leader at the Institute of Molecular Genetics.

Overall, Serguei Nabirotchkine, PhD has made significant contributions to the field of biology and genetics through their research and leadership positions, with a focus on the discovery and development of new therapeutics for various diseases.

Serguei Nabirotchkine pursued their education at Lomonosov Moscow State University (MSU) in the field of Biology and Genetics. Serguei completed their high school education at MSU from 1976 to 1981. Building on their knowledge and passion for the subject, they went on to earn their Doctor of Philosophy (Ph.D.) degree from the same institution from 1981 to 1984, specializing in Biology and Genetics.